Skip to main content
Premium Trial:

Request an Annual Quote

Affy Facility Closing Tops Most-Read GenomeWeb News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Sept. 15.
1. Affymetrix to Shutter, Consolidate Massachusetts Manufacturing and Development Facility (from Sept. 14)
2. Hopkins Study Hints at Role for Next-Gen Methods in Cancer Genome Sequencing; ABI's Agencourt Platform to Be Validated (from Sept. 12)
3. MAQC Publishes Results of Large-Scale Comparative Microarray Study, Says Cross-Platform Data Are 'Reproducible and Comparable' (from Sept. 11)
4. NIH Picks Lung, Ovarian, and Brain Cancers for Cancer Genome Atlas Project (from Sept. 13)
5. Jury Awards Innogenetics $7M in HCV Patent Case Against Abbott (from Sept. 11)
The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.